Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | DRD2 | P14416 | 1/20 | 0.62 |
| ▸ | DRD4 | P21917 | 1/20 | 0.62 |
| ▸ | DRD3 | P35462 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.59 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | APP | P05067 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL542239 | 0.90 | TDP1 (0.74) | NAAATDP1LMNATSHRALDH1A1 | |
| SCHEMBL4551634 | 0.90 | GAA (0.61) | NAAATDP1DRD2DRD4DRD3 | |
| SCHEMBL13875528 | 0.89 | SMN1; SMN2 (0.69) | TDP1GAALMNATSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL7576777 | 0.89 | TDP1 (0.72) | NAAATDP1LMNATSHRALDH1A1 | |
| SCHEMBL23786281 | 0.88 | TDP1 (0.65) | NAAATDP1DRD2DRD4DRD3 | |
| SCHEMBL14679112 | 0.86 | L3MBTL1 (0.65) | DRD2DRD4DRD3GAALMNA | |
| SCHEMBL28274478 | 0.86 | LMNA (0.61) | DRD2DRD4DRD3LMNATSHR | |
| SCHEMBL9259700 | 0.86 | SMN1; SMN2 (0.65) | GAAALDH1A1ACHEMEN1CYP2D6 | |
| SCHEMBL9364516 | 0.84 | POLB (0.71) | DRD2DRD4DRD3LMNATSHR | |
| SCHEMBL14797432 | 0.84 | LMNA (0.56) | DRD2DRD4DRD3GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0145654-B2 | METHOD OF LINING THE INSIDES OF PIPES OR PARTS OF PIPES | CIBA-GEIGY AG (CH) | 1992-05-13 | — | — | EP | claimed |
| US-4762585-A | EPOXY RESINS WITH AMINE CURING AGENTS | CIBA-GEIGY CORPORATION (US) | 1988-08-09 | — | — | US | claimed |
| EP-0145654-B1 | METHOD OF LINING THE INSIDES OF PIPES OR PARTS OF PIPES | CIBA-GEIGY AG (CH) | 1987-11-25 | — | — | EP | claimed |
| EP-0145654-A1 | Method of lining the insides of pipes or parts of pipes | CIBA-GEIGY AG (CH) | 1985-06-19 | — | — | EP | claimed |
| US-20230181524-A1 | PHARMACEUTICAL COMBINATION AND USE THEREOF | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| EP-4129282-A1 | PHARMACEUTICAL COMBINATION AND USE THEREOF | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2023-02-08 | — | — | EP | disclosed |
| CN-115427032-A | Pharmaceutical composition and use thereof | 浙江养生堂天然药物研究所有限公司 | 2022-12-02 | — | — | CN | disclosed |
| EP-0145654-B2 | METHOD OF LINING THE INSIDES OF PIPES OR PARTS OF PIPES | CIBA-GEIGY AG (CH) | 1992-05-13 | — | — | EP | disclosed |
| US-4845234-A | IN SITU LINING OF PIPE INTERIORS, CURING AGENTS FOR EPOXY RESINS | CIBA-GEIGY CORPORATION (US) | 1989-07-04 | — | — | US | disclosed |
| US-4762585-A | EPOXY RESINS WITH AMINE CURING AGENTS | CIBA-GEIGY CORPORATION (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0145654-B1 | METHOD OF LINING THE INSIDES OF PIPES OR PARTS OF PIPES | CIBA-GEIGY AG (CH) | 1987-11-25 | — | — | EP | disclosed |
| EP-0145654-A1 | Method of lining the insides of pipes or parts of pipes | CIBA-GEIGY AG (CH) | 1985-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181524-A1 | PHARMACEUTICAL COMBINATION AND USE THEREOF | TCF4, TCF7L2, CTNNB1 | NAAA 4790/4885TDP1 3665/4885DRD2 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.